Vinod Varki is an Oncology physician affiliated with Mercy Medical Center. OpenAlex indexes 8 publications with 277 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5008 Brittonfield Pkwy
East Syracuse, NY 130579248
Telephone
315-472-7504Provider last certified this registry record 19 Aug 2020.
Industry payments
43 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20256 payments
- Novartis Pharmaceuticals CorporationProgram year202514 payments
- Incyte CorporationProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
66%Erythropoiesis-stimulating Agent53.5%Darbepoetin alfa100%Part B, office-administered≥18 patientsIron, parenteral preparations12.5%Ferric derisomaltose100%Part B, office-administered≥26 patients+ 1 more class in this area
Metabolism & gastrointestinal
29.9%Other antiemetics26.5%Fosaprepitant100%Part B, office-administered≥14 patientsSerotonin-3 Receptor Antagonist3.3%Palonosetron hcl100%Part B, office-administered≥17 patientsSensory organs
3.9%Corticosteroid3.9%Dexamethasone sodium phosphate100%Part B, office-administered≥19 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- PD-L1, B7-H3, and PD-1 expression in immunocompetent vs. immunosuppressed patients with cutaneous squamous cell carcinoma
Cancer Immunology Immunotherapy
2018 - Targeting of Radiation Inducible Antigen on Human Lung Cancer Cells
International Journal of Radiation Oncology*Biology*Physics
2012 - MLN8054, A Small Molecule Inhibitor of Aurora Kinase A, Sensitizes Androgen-Resistant Prostate Cancer to Radiation
International Journal of Radiation Oncology*Biology*Physics
2011
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Thuluvath, MD
Mercy Medical Center
Sergey Kantsevoy, MD
Mercy Medical Center
Lew Schon, MD
Mercy Medical Center
Joseph Doerer, MD
Mercy Medical Center
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”